Harvard Apparatus Regenerative Technology, Inc.

HOLLISTON, MA · Founded 2012 · Biotech · Public

Tissue-engineered scaffolds seeded with patient stem cells to repair damaged organ tissue

Claim this profile

Follows are private to you and power your alerts

Updated · hregen.com

Sector
Biotech
Headquarters
HOLLISTON, MA
Founded
2012
Latest Form D
$2.8M, Sep 2026
Total capital
$37.4M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$37.4M
15 Form D · last Sep 2026
1 months since last filing
Federal contracts
$22K
4 awards · Veterans Affairs, Agriculture, Health and Human S
Rank in Biotech#370 of 4373
Granted patents
2
11 pending · first 2024
Rank in peer group#4 of 32

Capital timeline

2014201620182020202220242026FEDERAL ↑EQUITY ↓Cumulative $37.4M$6K$7K$6K1st Form D$5M
2014201820222026FEDERAL ↑EQUITY ↓Cumulative $37.4M$6K$7K1st Form D$5M

Latest events

  • Private capital raisedForm D · SEC · 15th filing$2.8M
  • Private capital raisedForm D · SEC · 14th filing$700K
  • Private capital raisedForm D · SEC · 13th filing$2M
  • Private capital raisedForm D · SEC · 12th filing$1.5M
  • Private capital raisedForm D · SEC · 11th filing$6M
  • Private capital raisedForm D · SEC · 10th filing$5.1M
  • Private capital raisedForm D · SEC · 9th filing$600K
  • Private capital raisedForm D · SEC · 8th filing$500K
  • Private capital raisedForm D · SEC · 7th filing$2.2M
  • Private capital raisedForm D · SEC · 6th filing$1.3M
  • Private capital raisedForm D · SEC · 5th filing$900K
  • Private capital raisedForm D · SEC · 4th filing$3.6M
  • Private capital raisedForm D · SEC · 3rd filing$1M
  • Private capital raisedForm D · SEC · 2nd filing$4.2M
  • Private capital raisedForm D · SEC · 1st filing$5M
Show 4 earlier federal awards
  • Federal contractHealth and Human S · Laboratory Equipment And Supplies$6K
  • Federal contractHealth and Human S · Laboratory Equipment And Supplies$3K
  • Federal contractAgriculture · Igf::ot::igf Phd Ultra 4400 High Pressure Syringe Pump And Stainless Steel Syringe$7K
  • Federal contractVeterans Affairs · Mitocell Respiration System 300-1000$6K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

21months

from Harvard Apparatus Regenerative Technology, Inc.’s first federal award to its first private round.

First federal award · Sep 2014
Veterans Affairs · $6K
First Form D · Jun 2016
$5M · 1st Form D
Awards before first raise
4 awards

An association in public records, not a cause or a prediction.

Standing among 32 peers

Line = median

Biotech · Device

  • Granted patents#4 · top 13%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • David GreenDirectorNamed in SEC Form D filings
  • Herman SanchezDirectorNamed in SEC Form D filings
  • Hong YuExecutive OfficerNamed in SEC Form D filings
  • James ShmerlingDirectorNamed in SEC Form D filings
  • Jing ChenDirectorNamed in SEC Form D filings
  • Joseph DamasioExecutive OfficerNamed in SEC Form D filings
Show all 12 people
  • Junli HeExecutive Officer, DirectorNamed in SEC Form D filings
  • Mao ZhangDirectorNamed in SEC Form D filings
  • Ronald PackardDirectorNamed in SEC Form D filings
  • Shunfu HuExecutive OfficerNamed in SEC Form D filings
  • Ting LiDirectorNamed in SEC Form D filings
  • William FodorExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 13
Show all 13 patent records
  • Method And Device For In Vivo Tissue Regeneration On The Interior Surface Of Hollow OrgansOct 21, 2025 · US 12,447,230Granted
  • Methods And Compositions For Promoting The Structural Integrity Of Scaffolds For Tissue EngineeringApr 17, 2025 · Application 18781577Pending
  • Method And Device For In Vivo Bronchus RegenerationFeb 6, 2025 · Application 18921769Pending
  • Systems And Methods For Producing Gastrointestinal Tissues At An Anastomosis Or Other Physiological LocationAug 8, 2024 · Application 18599990Pending
  • Systems And Methods For Producing Gastrointestinal Tissues At An Anastomosis Or Other Physiological LocationJul 30, 2024 · US 12,048,619Granted
  • Methods And Compositions For Promoting The Structural Integrity Of Scaffolds For Tissue EngineeringJul 4, 2024 · Application 18405658Pending
  • Systems And Methods For Minimizing Fibrotic Scar Formation Subsequent To Trauma In Tubular OrgansFeb 1, 2024 · Application 18228828Pending
  • Meshes And Patches For Tissue RepairApplication PCTUS2014058698Pending
  • Bioreactors And Uses ThereofApplication PCTUS2014032025Pending
  • Bioreactor ConnectorsApplication PCTUS2014030030Pending
  • Systems And Methods For Minimizing Fibrotic Scar Formation Subsequent To Trauma In Tubular OrgansApplication PCTUS2023029176Pending
  • Systems And Methods For Producing Gastrointestinal TissuesApplication 62276715Pending
  • Systems And Methods For Producing Gastrointestinal TissuesApplication 62254700Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .